Case Studies

Craig I. Coleman, PharmD, and Diana M. Sobieraj, PharmD
Published Online: Friday, October 11, 2013
Follow Pharmacy_Times:
Case 1
IC, a 38-year-old man, arrives at the pharmacy with new prescriptions for Delzicol (mesalamine) capsules (dosage: three 400-mg capsules twice daily) and Canasa (mesalamine) suppositories (dosage: one 1000-mg suppository at bedtime). IC tells the pharmacist he was recently discharged from the hospital with a diagnosis of acute, mild to moderate ulcerative colitis and that his colonoscopy showed inflammation of his entire colon. IC says he is feeling better, having only 2 to 3 bouts of non-bloody diarrhea a day, but often has to use the bathroom in the middle of the night. The pharmacist gives IC his 2 prescriptions and, while explaining their use, says they both contain the same active ingredient—mesalamine. IC asks, “Why do I need to take the same drug in 2 different ways?”
How should the pharmacist respond to IC?

Case 2
ZK is a 32-year-old man who regularly comes to your pharmacy. He tried to quit smoking last year but failed because he followed the warning on the package that said “Do not use if you continue to smoke.” Although he tried to stop smoking cigarettes the day he began using the patch, he was unable to sustain this and, after a few days, stopped his attempt to quit smoking. Today, ZK comes to your pharmacy to talk to you about quitting again.
What information can the pharmacist provide to ZK?
Dr. Coleman is associate professor of pharmacy practice and director of the pharmacoeconomics and outcomes studies group, and Dr. Sobieraj is assistant professor of pharmacy practice, at the University of Connecticut School of Pharmacy.


Related Articles
The My GI Health tool tracks symptoms of gastroesophageal reflux disease over time, helping clinicians save time and improve patient care.
In several countries, increases in the incidence of inflammatory bowel disease have been observed closely following regulatory approval of sucralose.
Community pharmacists need to expand their comfort zones regarding chemotherapy.
Latest Issues
$auto_registration$